中文 | English
Return
Total: 322 , 1/33
Show Home Prev Next End page: GO
Author:(Yong Sheng ZHOU)

4.Experience in the treatment of severe pressure sore.

Xi-Sheng XU ; Zheng-Zheng MA ; Yong-Sheng ZHOU ; Cai-Sheng OU ; Yong CHENG ; Kai CHEN ; Bo-Tong LI ; Hai-Yang ZHOU ; Yong-Cai HU

Chinese Journal of Plastic Surgery 2011;27(6):405-410

5.Design, synthesis and Na+/H+ exchanger isoform-1 inhibitory activity of feruloylagmatine analogues.

Jiaming LI ; Yong HE ; Peng ZHOU ; Yungen XU ; Jiazhi PENG ; Rizheng SHENG

Acta Pharmaceutica Sinica 2011;46(8):936-41

6.Investigation on the role on perindopril for prevention and treatment of glucocorticoid-induced osteoporosis in rabbits.

Feng ZHOU ; Chun RONG ; Kai WANG ; Chun-sheng WANG ; Yong-tao ZHANG

China Journal of Orthopaedics and Traumatology 2016;29(1):52-57

7.Preparation technology and dissolution research of Blumea volatile oil suppository.

Song WANG ; Yong-Heng ZHAO ; Yi-Sheng ZHOU ; Fang-Fang LI

China Journal of Chinese Materia Medica 2014;39(10):1805-1810

8.An improved novel method of venlafaxine synthesis.

Rong SHENG ; Tao LIU ; Yong-zhou HU

Journal of Zhejiang University. Medical sciences 2004;33(1):77-79

9.Improved method of fluvoxamine synthesis.

Tao LIU ; Rong SHENG ; Yong-zhou HU

Journal of Zhejiang University. Medical sciences 2003;32(5):441-442

10.PI3 K/Akt/Sirt1 signaling pathway mediated hydrogen sulfide postconditioning-induced protection against I/R injury

Mingzhu HU ; Bo ZHOU ; Qiong SHENG ; Bin DU ; Junliang CHEN ; Qingfeng PANG ; Yong JI

Chinese Pharmacological Bulletin 2016;(2):268-273

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 322 , 1/33 Show Home Prev Next End page: GO